American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

February 18, 2016

Newsletter Sponsor

Pfanstiehl is expanding its HPAPI CDMO offerings
with immediate capacity availability and a wider array of process chemistry expertise
Pfanstiehl has invested in capacity, state of the art equipment, and people who have a passion for developing solutions for clients with complex chemistry challenges. Pfanstiehl’s ideal partner is one who is looking for a CDMO partner that will walk lockstep with them through their drug development lifecycle. We work with firms who really value personalized attention and excellence in execution. We are selective with the programs we take on, so that each one has every opportunity for success.

	Industry News

AMRI Announces Fourth Quarter and Full Year 2015 Results and Provides 2016 Outlook

FDA Approves Impax’s Generic Version of Adderall XR®

Aldevron Appoints Vice President and General Manager

Capsugel and Pulmatrix to Develop and Manufacture Novel Inhaled Therapeutics

Asterand Bioscience Awarded Five-Year, $6.5M Contract from the National Institutes of Health (NIH)

Pharmaceutical Packaging Companies Form Matrix Alliance to Help Manufacturers Speed Treatments to Market

	Featured Articles

Trends Affecting CROs & CMOs in 2016 Look Positive Trends Affecting CROs & CMOs in 2016 Look Positive While CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is getting a lot of attention as this year’s potential wonder therapy, the generics industry continues to undergo change. ... read more »

Single-Use Now Key Technology in Biopharmaceutical Manufacturing Single-Use Now Key Technology in Biopharmaceutical Manufacturing Predictions for healthy growth in demand for biologic drugs are driving many manufacturers, including branded and biosimilar drug producers and contract manufacturers, to invest in new production ... read more »

	Featured Video

Interview with INC Research at DIA 2015
Interview with INC Research at DIA 2015
In this video, Mike Auerbach of Pharmaceutical Outsourcing speaks with John Whitaker, Ph.D., VP of Clinical Innovation at INC Research. Learn about how INC Research is using disruptive innovation to ... read more »

Interview with MPI Research at AAPS 2015
Interview with MPI Research at AAPS 2015
In this video, Mike Auerbach speaks with Lisa Yoder and Katie Jeschke from MPI Research about the CRO services MPI provides and how they are setting themselves apart in the industry. MPI Research ... read more »

	Events


2016 PDA Annual Meeting		DCAT Week ‘16

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA